Topic and style: Authorship attribution with multi-vector meta-features and stacked classifier
International Journal on Information Technologies and Security · 2025
DOI: 10.59035/btrz6248 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal on Information Technologies and Security, 2025. Verfasst von B. Lavanya und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Authorial rights are meaningful only when a document is promptly attributed to its legitimate creator. While an author’s unique topical preferences may pinpoint them within a group of thematically-diverse writers, attribution becomes considerably challenging in cases such as judicial opinions – e.g., attributing a criminal case judgement to one among hundreds of judges heading criminal courts – due to overlapping contextual jargon. In such situations, integrating both topical and stylistic cues can enhance the reliability and generalisability of authorship attribution. This work proposes a custom stacking ensemble model trained on diverse aspects of text, later giving rise to novel features: Multi-Vector Meta-Features. The proposed method demonstrates statistically significant boosted accuracy scores across three out of four datasets, outperforming baseline model and recent stacking ensemble models.
Zitieren
APA
Lavanya, B., & Sowmiya, R. (2025). Topic and style: Authorship attribution with multi-vector meta-features and stacked classifier. International Journal on Information Technologies and Security. https://doi.org/10.59035/btrz6248
Vancouver
Lavanya B, Sowmiya R. Topic and style: Authorship attribution with multi-vector meta-features and stacked classifier. International Journal on Information Technologies and Security. 2025. doi:10.59035/btrz6248
BibTeX
@article{Lavanya2025,
author = {Lavanya, B. and Sowmiya, R.},
title = {Topic and style: Authorship attribution with multi-vector meta-features and stacked classifier},
journal = {International Journal on Information Technologies and Security},
year = {2025},
doi = {10.59035/btrz6248}
}
EUVIMED